dc.contributor.author | CLEARY, A. | |
dc.contributor.author | WALSH, F. | |
dc.contributor.author | CONNOLLY, H. | |
dc.contributor.author | HAYS, V. | |
dc.contributor.author | OLUWOLE, B. | |
dc.contributor.author | MACKEN, E. | |
dc.contributor.author | Dowling, Maura | |
dc.date.accessioned | 2018-09-20T16:03:29Z | |
dc.date.available | 2018-09-20T16:03:29Z | |
dc.date.issued | 2011-09-14 | |
dc.identifier.citation | CLEARY, A. WALSH, F.; CONNOLLY, H.; HAYS, V.; OLUWOLE, B.; MACKEN, E.; DOWLING, M. (2011). Monitoring and documentation of side effects from depot antipsychotic medication: an interdisciplinary audit of practice in a regional mental health service. Journal of Psychiatric and Mental Health Nursing 19 (5), 395-401 | |
dc.identifier.issn | 1351-0126 | |
dc.identifier.uri | http://hdl.handle.net/10379/10808 | |
dc.description.abstract | This audit reviewed current practice within a rural mental health service area on the monitoring and documentation of side effects of antipsychotic depot medication. A sample of 60 case files, care plans and prescriptions were audited, which is 31% of the total number of service users receiving depot injections in the mental health service region (n= 181). The sample audited had a range of diagnoses, including: schizophrenia, schizoaffective disorder, bipolar affective disorder, depression, alcoholic hallucinosis and autism. The audit results revealed that most service users had an annual documented medical review and a documented prescription. However, only five (8%) case notes examined had documentation recorded describing the condition of the injection site, and alternation of the injection site was recorded in only 28 (47%) case notes. No case notes examined had written consent to commence treatment recorded. In 57 (95%) of case notes, no documentation of recorded information on the depot and on side effects was given. The failure to monitor and record some blood tests was partly attributed to a lack of clarity regarding whose responsibility it was. A standardized checklist has been developed as a result of the audit and this will be introduced by all teams across the service. | |
dc.publisher | Wiley-Blackwell | |
dc.relation.ispartof | Journal of Psychiatric and Mental Health Nursing | |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 Ireland | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/3.0/ie/ | |
dc.subject | antipsychotics | |
dc.subject | audit | |
dc.subject | depot | |
dc.subject | mental health | |
dc.subject | metabolic syndrome | |
dc.subject | side effects | |
dc.subject | schizophrenia | |
dc.subject | people | |
dc.subject | akathisia | |
dc.subject | community | |
dc.subject | nurses | |
dc.title | Monitoring and documentation of side effects from depot antipsychotic medication: an interdisciplinary audit of practice in a regional mental health service | |
dc.type | Article | |
dc.identifier.doi | 10.1111/j.1365-2850.2011.01807.x | |
dc.local.publishedsource | https://www.lenus.ie/bitstream/10147/302493/1/Cleary2012Pre-peer.pdf | |
nui.item.downloads | 0 | |